Incline Global Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-121,778
Closed -$21.7M 24
2015
Q3
$21.7M Buy
121,778
+30,410
+33% +$7.09M 4.79% 10
2015
Q2
$20.3M Sell
91,368
-1,142
-1% -$253K 4.5% 10
2015
Q1
$18.4M Sell
92,510
-6,060
-6% -$1.08M 4.57% 11
2014
Q4
$14.1M Buy
98,570
+5,960
+6% +$802K 4.17% 8
2014
Q3
$12.2M Buy
92,610
+5,450
+6% +$650K 3.64% 4
2014
Q2
$11M Buy
87,160
+26,560
+44% +$3.39M 4.12% 3
2014
Q1
$7.99M Buy
60,600
+10,750
+22% +$1.47M 4.33% 7
2013
Q4
$5.85M Buy
+49,850
New +$5.46M 3.75% 17

Other funds holding BHC

Incline Global Management's BHC Position: Q4 2015 in Review

Incline Global Management sold out of Bausch Health (BHC) in Q4 2015, closing a stake of 121,778 shares — an estimated $21.7M sold.

Incline Global Management first reported a position in BHC in Q4 2013 and held it in 8 quarters. The position peaked at $21.7M in Q3 2015. 451 funds tracked by Wall St. Rank hold BHC as of Q4 2015.

  • Incline Global Management reported no remaining Bausch Health position as of Q4 2015 after selling out during the quarter.
  • Incline Global Management sold 121,778 Bausch Health shares in Q4 2015, an estimated $21.7M.
  • Incline Global Management first reported a position in Bausch Health in Q4 2013 and held it in 8 quarters.
  • Incline Global Management's Bausch Health position peaked at $21.7M in Q3 2015.
  • 451 funds tracked by Wall St. Rank held Bausch Health as of Q4 2015.

Based on Incline Global Management's 13F filing for Q4 2015, filed 16 Feb 2016.